Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin-Reference-Cited by-同舟云学术

Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza Hemagglutinin

Published:2011-03-28 Issue:3 Volume:6 Page:e18314
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Weaver Eric A.,Rubrum Adam M.,Webby Richard J.,Barry Michael A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Influenza Fact Sheet,2009

2. Changes in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice.;AK Gitelman;Virology,1984

3. The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.;ED Kilbourne;Proc Natl Acad Sci U S A,2002

4. Evidence for host-cell selection of influenza virus antigenic variants.;GC Schild;Nature,1983

5. Update: influenza activity–United States and worldwide, 1997-98 season, and composition of the 1998-99 influenza vaccine.;MMWR Morb Mortal Wkly Rep,1998

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza B Virus Vaccine Innovation through Computational Design;Pathogens;2024-09-02

2. Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus;Vaccines;2022-06-10

3. Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences;Molecular Therapy;2022-05

4. Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26);Journal of Virology;2022-02-09

5. Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26);2021-10-01